The researchers conducted a randomized controlled trial of chlorhexidine bathing. Hospitalized patients are sometimes bathed in a solution of chlorhexidine gluconate (CHG), a topical antiseptic, to reduce the spread of infections. S. epidermidis is an important cause of infections in patients with implanted medical devices. Bathing with CHG has been shown to reduce rates of device-associated infections.
The primary goal of the study was to determine whether bathing in CHG reduced the risk of bloodstream infections associated with central venous catheters. The discovery of the new gene variant was an unanticipated result of that study, said coauthor Xuan Qin, PhD, D(ABMM), Associate Professor, UW Lab Medicine, the University of Washington School of Medicine.
Investigators - Isolates - S - Epidermidis - Skin
The investigators obtained isolates of S. epidermidis from the skin of children enrolled in the study. "We obtained the cutaneous bacteria by swabbing the children's skin at the beginning, middle, and end of the...
Wake Up To Breaking News!
NY Times, a small niche paper for a small niche people in a really big internet